Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Kevin Andrew Robbins bought 7,100 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $4.17 per share, with a total value of $29,607.00. Following the completion of the purchase, the director owned 33,333 shares in the company, valued at approximately $138,998.61. The trade was a 27.07% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Mannatech Price Performance
Shares of MTEX opened at $4.37 on Friday. The firm has a market cap of $8.43 million, a PE ratio of -0.65 and a beta of 0.61. The company has a current ratio of 1.09, a quick ratio of 0.59 and a debt-to-equity ratio of 0.48. The firm has a fifty day simple moving average of $5.48 and a two-hundred day simple moving average of $7.22. Mannatech, Incorporated has a 1-year low of $3.80 and a 1-year high of $12.45.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. The business had revenue of $24.92 million during the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%.
Mannatech Company Profile
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Articles
- Five stocks we like better than Mannatech
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
